Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Hopkins

Showing results (741-750 of 884) with videos related to

Pageof 89
Sort By:
Bioorganic Chemistry|March 30, 2026
Urea-based lysophosphatidic acid receptor 1 antagonists as potential migrastatics for triple-negative breast cancerWenjie Liu, Amr A K Mousa, Guillem Dayer, et al.
American Journal of Preventive Medicine|August 5, 2019
Dual Versus Never Use of E-Cigarettes Among American Indians Who SmokeDorothy A Rhoades, Ashley L Comiford, Justin D Dvorak, et al.
The New England Journal of Medicine|February 2, 1995
Methotrexate for the treatment of Crohn's disease. The North American Crohn's Study Group InvestigatorsB G Feagan, J Rochon, R N Fedorak, et al.
Muscle & Nerve|August 1, 2009
A RYR1 mutation associated with recessive congenital myopathy and dominant malignant hyperthermia in Asian familiesDanielle Carpenter, Azzam Ismail, Rachel L Robinson, et al.
JNCI Cancer Spectrum|January 8, 2026
Heterogeneous Treatment Effect of Immune Checkpoint inhibitors by Pre-treatment Prognosis in Randomised Controlled TrialsLee X Li, Adel Shahnam, Ganessan Kichenadasse, et al.
Anaesthesia|September 15, 2025
Penicillin allergy risk stratification tool for use by non-allergists in the peri-operative setting: an agreement study and qualitative process evaluationPriyanthi Dias, Emma Walshaw, Sam Flatau, et al.
Antimicrobial Agents and Chemotherapy|August 21, 2019
First-in-Human Phase 1 Study To Assess Safety, Tolerability, and Pharmacokinetics of a Novel Antifungal Drug, VL-2397, in Healthy AdultsMammen P Mammen, Danielle Armas, Frank H Hughes, et al.
International Journal of Cancer|May 15, 1990
Phenotypic characterization, karyotype analysis and in vitro tamoxifen sensitivity of new ER-negative vulvar carcinoma cell lines, UM-SCV-1A and UM-SCV-1BS E Grénman, D L Van Dyke, M J Worsham, et al.
International Journal of Cancer|June 18, 2009
JAM-A expression positively correlates with poor prognosis in breast cancer patientsElaine A McSherry, Sharon F McGee, Karin Jirstrom, et al.
European Journal of Cancer (Oxford, England : 1990)|December 22, 2023
Objective response rate and progression-free survival as surrogates for overall survival treatment effect: A meta-analysis across diverse tumour groups and contemporary therapiesAdel Shahnam, Nadia Hitchen, Udit Nindra, et al.
Pageof 89

Showing results (741-750 of 884) with videos related to

Sort By:
Pageof 89
Bioorganic Chemistry|March 30, 2026
Urea-based lysophosphatidic acid receptor 1 antagonists as potential migrastatics for triple-negative breast cancerWenjie Liu, Amr A K Mousa, Guillem Dayer, et al.
American Journal of Preventive Medicine|August 5, 2019
Dual Versus Never Use of E-Cigarettes Among American Indians Who SmokeDorothy A Rhoades, Ashley L Comiford, Justin D Dvorak, et al.
The New England Journal of Medicine|February 2, 1995
Methotrexate for the treatment of Crohn's disease. The North American Crohn's Study Group InvestigatorsB G Feagan, J Rochon, R N Fedorak, et al.
Muscle & Nerve|August 1, 2009
A RYR1 mutation associated with recessive congenital myopathy and dominant malignant hyperthermia in Asian familiesDanielle Carpenter, Azzam Ismail, Rachel L Robinson, et al.
JNCI Cancer Spectrum|January 8, 2026
Heterogeneous Treatment Effect of Immune Checkpoint inhibitors by Pre-treatment Prognosis in Randomised Controlled TrialsLee X Li, Adel Shahnam, Ganessan Kichenadasse, et al.
Anaesthesia|September 15, 2025
Penicillin allergy risk stratification tool for use by non-allergists in the peri-operative setting: an agreement study and qualitative process evaluationPriyanthi Dias, Emma Walshaw, Sam Flatau, et al.
Antimicrobial Agents and Chemotherapy|August 21, 2019
First-in-Human Phase 1 Study To Assess Safety, Tolerability, and Pharmacokinetics of a Novel Antifungal Drug, VL-2397, in Healthy AdultsMammen P Mammen, Danielle Armas, Frank H Hughes, et al.
International Journal of Cancer|May 15, 1990
Phenotypic characterization, karyotype analysis and in vitro tamoxifen sensitivity of new ER-negative vulvar carcinoma cell lines, UM-SCV-1A and UM-SCV-1BS E Grénman, D L Van Dyke, M J Worsham, et al.
International Journal of Cancer|June 18, 2009
JAM-A expression positively correlates with poor prognosis in breast cancer patientsElaine A McSherry, Sharon F McGee, Karin Jirstrom, et al.
European Journal of Cancer (Oxford, England : 1990)|December 22, 2023
Objective response rate and progression-free survival as surrogates for overall survival treatment effect: A meta-analysis across diverse tumour groups and contemporary therapiesAdel Shahnam, Nadia Hitchen, Udit Nindra, et al.
Pageof 89